NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 06/18/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.27 mln
Float0.63 mln
Earnings Date08/15/2026
EPS
4.00
Solid
P / E
1.27
Deeply undervalued
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
90.09
Exceptional
Dividend Yield
0.00%
No dividend
Business Description
Advanced Biomed Inc. is a New York-based investment holding company, founded in 2014, that develops advanced microfluidic biochip technology aimed at detecting, diagnosing, and treating cancer with greater precision. The company produces a range of devices and diagnostic kits designed to identify and analyze rare cancer cells circulating in the blood, helping clinicians better understand a patient's tumor profile. It also provides related testing products and services directly to cancer patients, while working on new tools for early lung cancer screening. In addition, the company owns and runs medical clinics in China.
